Get Started

SNTI

NASD Senti Biosciences Holdings Inc
Oct 27, 2026 · 7:41 PM ET LAST TRADE Market Closed

$0.2177 ↑ +0.0310 (+16.60%) Trading Up from the previous close of $0.1867, and at the day’s high of $0.1950

YTD change
-79.07%
vs 20-day SMA
-19.78%
vs 200-day SMA
-70.67%

Price ranges

Previous day
$0.1706 $0.1860
open $0.1860 close $0.1751
-$0.0109 (-5.86%)
Today
$0.1560 $0.1950
open $0.1682 now $0.2177
+$0.0495 (+29.43%)
Past week
$0.1701 $0.2300
from $0.2268 now $0.2177
-$0.0091 (-4.01%)
Past month
$0.1701 $0.3500
from $0.3100 now $0.2177
-$0.0923 (-29.77%)
This year
$0.1560 $1.2000
from $1.0400 now $0.2177
-$0.8223 (-79.07%)

Price & Performance

-0.88 (-83.48%) / 6M

$0.1003$0.4618$0.8233$1.18Apr 27Jul 28Oct 26

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 99.8% away from all-time highs of $87.7000
  • SNTI is down 79% since the beginning of the year
  • SNTI is down 90% over the past 12 months
  • SNTI is down 30% over the past 1 month
  • 4% of all SNTI investors are betting against SNTI

SNTI reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -92.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.4094
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $19.2M
Beta 1.59

Balance sheet & scale

IncomeN/A
Revenue$55.0K
Cash$6.5M
Debt$20.2K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Market cap $6.8M

Operates as a holding company whose subsidiary develops cell and gene therapies for cancer diseases

Competitor comparison

No peer group available for this symbol.

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.